1. The role of cGAS-STING signalling in liver diseases
- Author
-
Jiamin Du, Ruihan Chen, Qi Ling, and Hong Zhu
- Subjects
nonalcoholic fatty liver disease ,cGAS-STING signalling ,ssRNA, single-stranded RNA ,Review ,SAVI, STING-associated vasculopathy with onset in infancy ,PD-L1, programmed cell death protein ligand-1 ,GVHD, graft-versus-host disease ,IFN-I, type I interferon ,TNF, tumour necrosis factor ,chemistry.chemical_compound ,NK cells, natural killer cells ,Immunology and Allergy ,ALD, alcohol-related liver disease ,dsDNA, double-strand DNA ,Toll-like receptor ,PD-1, programmed cell death protein-1 ,XRCC, X-ray repair cross complementing ,Gastroenterology ,Pattern recognition receptor ,hepatocellular carcinoma ,Cell biology ,TGF-β1, transforming growth factor-β1 ,Stimulator of interferon genes ,IRI, ischaemia refusion injury ,APCs, antigen-presenting cells ,DCs, dendritic cells ,HSCs, hepatic stellate cells ,liver injury ,TLR, Toll-like receptor ,AIM2, absent in melanoma 2 ,NAFLD, non-alcoholic fatty liver disease ,aHSCT, allogeneic haematopoietic stem cell transplantation ,viral hepatitis ,mTOR, mammalian target of rapamycin ,STING, stimulator of interferon genes ,Biology ,CDNs, cyclic dinucleotides ,ER, endoplasmic reticulum ,AIM2 ,Cyclic guanosine monophosphate–adenosine monophosphate ,PAMPs, pathogen-associated molecular patterns ,Internal Medicine ,MHC, major histocompatibility complex ,NPCs, non-parenchymal cells ,Innate immune system ,Hepatology ,IRF3, interferon regulatory factor 3 ,Pathogen-associated molecular pattern ,LSECs, liver sinusoidal endothelial cells ,PPRs, pattern recognition receptors ,eye diseases ,IL, interleukin ,mtDNA, mitochondrial DNA ,chemistry ,siRNA, small interfering RNA ,DAMPs, damage-associated molecular patterns ,TBK1, TANK-binding kinase 1 ,innate immune response ,KCs, Kupffer cells ,cGAMP, cyclic guanosine monophosphate-adenosine monophosphate ,cGAS, cyclic guanosine monophosphate-adenosine monophosphate synthase ,HCC, hepatocellular carcinoma ,IRF3 - Abstract
Summary The recently identified novel cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS) activates the downstream adaptor protein stimulator of interferon genes (STING) by catalysing the synthesis of cyclic GMP-AMP. This in turn initiates an innate immune response through the release of various cytokines, including type I interferon. Foreign DNA (microbial infection) or endogenous DNA (nuclear or mitochondrial leakage) can serve as cGAS ligands and lead to the activation of cGAS-STING signalling. Therefore, the cGAS-STING pathway plays essential roles in infectious diseases, sterile inflammation, tumours, and autoimmune diseases. In addition, cGAS-STING signalling affects the progression of liver inflammation through other mechanisms, such as autophagy and metabolism. In this review, we summarise recent advances in our understanding of the role of cGAS-STING signalling in the innate immune modulation of different liver diseases. Furthermore, we discuss the therapeutic potential of targeting the cGAS-STING pathway in the treatment of liver diseases.
- Published
- 2021